Lipoproteins play a central role in the development of atherosclerotic disease. So, with their
ability to affect lipid levels, the LDLR, ApoB and ApoE polymorphisms could be one of the …

Background Previous studies suggested that Apolipoprotein AI (ApoAI) and apolipoprotein B
(ApoB) gene polymorphisms may result in lipid metabolism disorders. Genetic …

ABSTRACT Interleukin‐1β (IL‐1β) is an inflammation‐causing cytokine that exerts several
unique biological effects and could lead to future adverse events of CAD. The piece of work …

Background There is a growing interest in the role of allelic variants of the APOA1 gene in
relation to a number of disorders. We described two common polymorphisms of the APOA1 …

Objective To retrospectively investigate the relationship between apolipoprotein E (APOE)
gene polymorphism and in-stent restenosis (ISR) after stenting at the beginning of the …

High density lipoprotein modulates the expression profile of various coagulation factors and
helps in prevention of many diseases through its main protein content ApoA1 which is anti …

Background: Lifestyle changes are important factors for managing dyslipidemia before
considering blood lipid-lowering drugs. However, genetic factors can influence the response …

Coronary artery disease (CAD) is a major cause of mortality and morbidity around the whole
world. The polymorphisms of Apolipoprotein AI (Apo-A1), including rs670 (-75 G/A) and …

Background: One of the most important metabolic disorders is hyperlipidemia. ApoAI protein
plays an important role in lipoprotein metabolism. In this study, the association between …

Objective: The underlying molecular basis of ischemic heart diseases (IHDs) has not yet
been studied among Iraqi people. This study determined the frequency and types of some …